Raymond James Financial
AUPH icon

Raymond James Financial’s Aurinia Pharmaceuticals AUPH Stock Holding History

Raymond James Financial’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.27M Buy
310,564
+44,807
+17% +$716K ﹤0.01% 2694
2026
Q1 		$3.94M Buy
265,757
+33,342
+14% +$487K ﹤0.01% 2786
2025
Q4 		$3.71M Sell
232,415
-3,708
-2% -$52.6K ﹤0.01% 2747
2025
Q3 		$2.61M Sell
236,123
-965
-0.4% -$10.5K ﹤0.01% 2962
2025
Q2 		$2.01M Buy
237,088
+213,758
+916% +$1.71M ﹤0.01% 3081
2025
Q1 		$188K Sell
23,330
-595
-2% -$4.82K ﹤0.01% 4439
2024
Q4 		$215K Buy
+23,925
New +$195K ﹤0.01% 4373

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Raymond James Financial's AUPH Position: Q2 2026 in Review

Raymond James Financial increased its Aurinia Pharmaceuticals (AUPH) stake by 17% in Q2 2026, buying an estimated $716K and bringing the position to 310,564 shares worth $5.27M. The position accounts for ﹤0.01% of the portfolio, ranked #2694.

Raymond James Financial first reported a position in AUPH in Q4 2024 and has held it in 7 quarters since. 282 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.

  • Raymond James Financial held 310,564 shares of Aurinia Pharmaceuticals worth $5.27M as of Q2 2026.
  • Raymond James Financial bought 44,807 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $716K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #2694 holding.
  • Raymond James Financial first reported a position in Aurinia Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 282 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.